Jilin Province Huinan Changlong Bio-pharmacy Co's EBIT per Share for the
six
months ended in Dec. 2025 was €0.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.06.
During the past 12 months, the average EBIT per Share Growth Rate of Jilin Province Huinan Changlong Bio-pharmacy Co was 20.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 11.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 10.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 2.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
STU:JIL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -46.3 Med: 9.1 Max: 71
Current: 11.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Jilin Province Huinan Changlong Bio-pharmacy Co was 71.00% per year. The lowest was -46.30% per year. And the median was 9.10% per year.
STU:JIL's 3-Year EBIT Growth Rate is ranked better than 55.5% of 809
companies
in the Drug Manufacturers industry
Industry Median: 7.6
vs STU:JIL: 11.30
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Jilin Province Huinan Changlong Bio-pharmacy Co EBIT per Share Related Terms
Jilin Province Huinan Changlong Bio-pharmacy Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co EBIT per Share Chart
Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a EBIT per Share of €0.06 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #360 out of 809 companies in the Drug Manufacturers industry, placing it in the top 44.5%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's EBIT per Share too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current EBIT per Share is €0.06. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #360 out of 809 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #360 out of 809 companies for EBIT per Share. This puts Jilin Province Huinan Changlong Bio-pharmacy Co in the upper half of its industry. The industry median EBIT per Share is 7.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.60, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current EBIT per Share is €0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a current EBIT per Share of €0.06. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current EBIT per Share is €0.06. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL), the current EBIT per Share is €0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Overvalued in 2026?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued.
The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.
Key valuation signals for STU:JIL:
EBIT per Share: €0.06
GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
No single metric tells the full story. See the STU:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jilin Province Huinan Changlong Bio-pharmacy Co Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score
Get the complete analysis for STU:JIL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:JIL has been successfully added to your 
